1. Background {#sec1}
=============

Asymptomatic bacteriuria (ASB) is a condition in which urine culture reveals a significant growth of bacteria which is greater than or equal to 10^5^ colony-forming unit per milliliter (ml) of urine taken from a clean catch midstream urine but without the patient showing symptoms such as genitourinary tract infection \[[@B1]\]. Pregnant women are two times more commonly affected than age-matched non-pregnant women. Asymptomatic bacteriuria can be symptomatic and asymptomatic urinary tract infection \[[@B1], [@B2]\].

Early screening and treating promptly of ASB during pregnancy can prevent further complication of bacteriuria in pregnant women \[[@B3]\]. According to the American College of Obstetricians and Gynecologists, screening of ASB is recommended in all pregnant women \[[@B2]\]. However, in many hospitals in developing countries including Ethiopia, routine urine culture test is not carried out for antenatal women probably due to cost implication and time factor for culture result (usually 48 hours period) \[[@B4]\].

Asymptomatic bacteriuria is one of the major risk factors for the development of UTIs during pregnancy which accounts for about 70% of the cases \[[@B5]\]. Globally, asymptomatic bacteriuria affects 2--10% of all pregnant women \[[@B6]\]. But it was reported at different level in different parts of the world.

The burden of this asymptomatic bacteriuria among pregnant women in Ethiopia also varies with the location of study \[[@B5], [@B7]--[@B10]\]. In Ethiopia, there is no guideline that recommends screening of ASB for the pregnant women regardless of the symptoms and sign. If untreated at the time of ASB, it causes about 40% of cystitis (infection of bladder) and 30% pyelonephritis (infection of kidney) \[[@B11]\]. It also affects the infants by causing premature delivery, low birth weight, intrauterine growth retardation, preterm labor, intrauterine fetal death, and in general, it increased prenatal mortality and morbidity \[[@B12]\]. It is estimated that 30--50% of pregnant women without on-time treatment of ASB in pregnancy will progress to symptomatic urinary tract infection. Therefore, appropriate screening and treatment of ASB will reduce the infection rate to 3% \[[@B4]\].

There are number of studies conducted in different part of the world about magnitude of asymptomatic bacteriuria, antimicrobials susceptibility and its associated factors for asymptomatic bacteriuria among pregnant women \[[@B1], [@B13]\]. However, to our information, there is no study conducted in Harar town. Therefore, this study was used to determine the magnitude of ASB, the drug susceptibility pattern, and associated factors of asymptomatic bacteriuria among pregnant women attending antenatal care (ANC) at Hiwot Fana Specialized University Hospital.

2. Methods and Materials {#sec2}
========================

2.1. Study Area, Design, and Period {#sec2.1}
-----------------------------------

An institutional based cross-sectional study was conducted on pregnant women attending antenatal care at Hiwot Fana Specialized University Hospital from March to April 2019. Hiwot Fana Specialized University Hospital is in Harari People\'s National Regional State, Harar, Eastern Ethiopia. Currently, the hospital serves to about 5.2 million communities around Harar and neighboring regions such as, Oromia Regional State, Dire Dawa Administrative Council, and Ethiopia Somali Regional State.

2.2. Sample Size Determination and Sampling Technique {#sec2.2}
-----------------------------------------------------

The sample size was determined using a single population formula taking a prevalence of ASB (21.2%) from the study conducted in Adigrat General Hospital \[[@B5]\] with the degree of precision set at 0.05 and at 95% confidence interval. The final sample size was 281. Study participants were selected by a convenient sampling technique.

2.3. Data Collection Methods {#sec2.3}
----------------------------

### 2.3.1. Data Collection Instruments {#sec2.3.1}

Data were collecetd using structured questionnaires developed from different literature \[[@B5], [@B9], [@B13]\]. The questionnaire contains two parts: sociodemographic characteristics and clinical and pregnancy-related factors. Laboratory examination of urine for the isolation of bacteria causing ASB and their antimicrobial susceptibility pattern was used to collect laboratorybased data.

### 2.3.2. Data Collection Procedure {#sec2.3.2}

First, all pregnant women who came for ANC services were screened whether they have signs and symptoms of UTI such as burning sensation, suprapubic pain, frequent urination, and fever, and then data were collected by the senior nurse from pregnant mothers who have no signs and symptoms of UTI. Other information such as history of hypertension, history of diabetes, and hemoglobin level were obtained from the medical record book of the pregnant women. Questionnairebased data were collected by face to face interview using pretested structured questionnaires.

The study participants were instructed how to collect 10--15 mL of standard midstream urine by the "clean catch" method. They were instructed to wash their hands, cleanse the genitals with clean water, dry the area with a sterile gauze pad, and collect the middle urine into a wide-mouthed screw-capped universal urine container with labia held apart. Then, study participants identification number, date, and time of collection were labelled on the outside of the container. The collected sample was kept in a cold box and sent to Haramaya University College of Health and Medical Sciences Department of Medical Laboratory Sciences within 30 minutes of collection time.

### 2.3.3. Urine Culture and Identification of Bacteria {#sec2.3.3}

The aseptically collected and well-mixed urine sample was inoculated onto CLED media, blood agar, and MacConkey agar (Oxoid, Ltd., UK) by streaking method using a standard calibrated wire loop having capacity of containing 0.001 ml of urine. The inoculated plates were incubated aerobically at 37°C for 18--24 hours \[[@B13]\]. Reinoculation was done for four media with growth not prominent enough to allow for decision on the identity of bacteria, other 24 hours required for reinoculation. Primary isolation of bacteria was made based on their colony characteristics. For instance, *E. coli* were lactose-fermenting mucoid colonies on MacConkey agar while *Proteus* spp. produced striking swarming colonies on the blood agar plate. Then, further identification of bacterial organism to species level was carried out by taking an isolated colony from a subculture and inoculated onto different biochemical media. In short, Gram-negative bacteria were identified by conducting a series of biochemical tests such as Kligler\'s Iron Agar (KIA), Sulphur Indole Motility (SIM) media, citrate, oxidase, urease, and catalase and coagulase were used for identification of Gram-positive bacteria.

Then, the confirmed colony was counted from CLED media and multiplied by 1000 to determine the number of bacteria per ml (CFU) of the original urine specimen. A specimen was considered positive for ASB if a single organism was growing at a concentration of ≥10^5^ colony-forming units/ml. A single isolated bacterium was inoculated onto nutrient agar slant and stored in a refrigerator after 24 hours of incubation for the maintenance of isolated bacteria.

### 2.3.4. Antimicrobial Susceptibility Testing {#sec2.3.4}

Antimicrobial susceptibility testing was performed using the disc diffusion method as described by the Clinical Laboratory Standards Institute \[[@B14]\]. In brief, the pure culture was transferred to a tube containing 5 ml sterile normal saline (0.85% NaCl) and mixed gently until it formed a homogeneous suspension. The turbidity of the suspension was adjusted to the optical density equivalent to 0.5 McFarland. A sterile cotton swab was then dipped into the suspension and the excess was removed by gentle rotation of the swab against the surface of the tube. The swab was distributed evenly over the entire surface of Mueller-Hinton agar (Oxoid, Ltd., UK).

The inoculated plates were left at room temperature to dry for 3 to 5 minutes. The antimicrobial discs (Oxoid, Ltd., UK) representative of the penicillin group (Amoxicillin 10 *μ*g, Augmentin 30 *μ*g, and Ampicillin 10 *μ*g), Cephalosporin (Ceftriaxone 30 *μ*g), aminoglycosides (Gentamycin 10 *μ*g), Maxolid (Erythromycin 15 *μ*g), Lincosamide (Clindamycin 2 *μ*g), Sulfonamide (Cotrimoxazole 25 *μ*g, and Tetracycline 10 *μ*g were placed on the inoculated plates and incubated at 37°C for 18--24 hours.

### 2.3.5. Operational Definition {#sec2.3.5}

*(1) Asymptomatic*. means pregnant women who do not have the sign and symptom of UTI.

*(2) Antimicrobial Susceptibility Pattern*. is defined as *sensitive* when the inhibition zone of the isolated bacteria is greater than the inhibition zone set for the antimicrobial disk mentioned in the testing panel, *resistant* when the inhibition zone of isolated bacteria is less than the inhibition zone set for the respective antimicrobial disk used in the testing panel, and *intermediate* when the inhibition zone of isolated bacteria is less or equal to the inhibition zone set for the antimicrobial disk mentioned in the testing panel (Oxoid, Ltd., UK).

*(3) Multidrug Resistance (MDR)*. refers to bacteria showing resistance by two or more than different groups of antimicrobial agents in the testing panel.

*(4) Significant Bacteriuria*. refers to the presence of ≥10^5^ colony-forming units per milliliter in the urine sample.

2.4. Method of Data Analysis {#sec2.4}
----------------------------

Data were double entered into EpiData version 3.1, cleaned, and exported to Statistical Package for Social Science (SPSS) version 22. Descriptive statistics were performed for different variables. The results were presented in texts, tables, and graphs using summary measures such as percentages, standard deviation, and mean. The magnitude of asymptomatic bacteriuria was determined as proportion of positive urine culture to the total pregnant women participated in this study. Logistic regression was carried out to identify the associated factors with asymptomatic bacteriuria. Variables with *p* value \<0.25 in bivariate analysis were considered as candidates for multivariable logistic regression to control confounder factors. The level of statistical significance was declared at *p* value \<0.05.

2.5. Quality Control {#sec2.5}
--------------------

A structured questionnaire initially prepared in English language was translated into Afan Oromo and Amharic by a language expert and translated back to English by another language expert. The questionnaire was pretested on 5% of the total sample size at the Jugal Hospital, Eastern Ethiopia, to ensure its validity. Completeness of each questionnaire was checked daily during data collection period.

The sterility of each medium was checked by incubating (3--5% of the batch) at 35--37°C overnight and looked for bacterial growth. The media which showed growth were discarded and replaced by a new sterile batch. The reference of American Type Culture Collection strains including *S. aureus* (ATCC 25923), *E. coli* (ATCC 25922), and *P. aeruginosa* (ATCC 27853) were used as a quality control throughout the study for culture and antimicrobial susceptibility test. Consistency of the entered data was validated by comparing the two separately entered data on EpiData version 3.1 (CDC/WHO, Atlanta, USA) by a data clerk having diploma in computer science. The frequencies of every variable were verified with the study population.

2.6. Ethical Consideration {#sec2.6}
--------------------------

The study protocol was reviewed and ethical clearance was obtained before starting the data collection process from the Institutional Health Research Ethics Review Committee (IHRERC) of the College of Health and Medical Sciences. Official letters of cooperation was submitted to Hiwot Fana Specialized University Hospital. The study participants were informed of their right to refuse or decline participation in the study at any time and that refusing to participate in the study will not affect them. Informed voluntary, written, and signed consent was obtained from all respondents before the study. The confidentiality of participants\' information was assured by excluding names and identifiers in the questionnaire.

3. Results {#sec3}
==========

3.1. Sociodemographic Characteristics of the Study Participants {#sec3.1}
---------------------------------------------------------------

In this study, a total of 281 asymptomatic pregnant women were included with a response rate of 99.3%. The age of the study participants ranges from 18 to 41 years with mean age ±standard deviations (SD) of 26.3 ± 5.7 years. Among the study participants, 91.8%, 44.8%, and 39.9% were married, urban dwellers, and with primary level education (1 to 8 grades), respectively. In addition to this, 64.4%, 34.2%, and 43.8% were house wife, primigravida, and at second trimester, respectively. Regarding participants\' average monthly income, about 32% of the study participants had average monthly income less than 1000 Ethiopian birr ([Table 1](#tab1){ref-type="table"}).

3.2. Clinical, Behavioral, and Pregnancy-Related Factors {#sec3.2}
--------------------------------------------------------

Among the study participants; 53.7%, 81.1%, and 58.4% had second antenatal care (ANC) visit, performed sexual activities less than two times per week, and the habit of postcoital washing, respectively. In addition to this, 76.9%, 60.1%, 37.5%, and 25.6% of the study participants had no habit of postcoital urination, wiped their genitals after washing from front to back direction, and history of UTI and antibiotic use before two weeks, respectively. Among the study participants; 8.5%, 5.7%, 17.8%, and 68.7% had history of hypertension, diabetes, catheterization, and anemia, respectively ([Table 2](#tab2){ref-type="table"}).

3.3. Asymptomatic Bacteriuria and Types of Bacterial Isolates {#sec3.3}
-------------------------------------------------------------

In this study, the overall prevalence of significant bacteriuria was 19.9% (95% CI: 16.4% to 24.6%). Six different bacterial isolates were identified. Gram-negative bacteria were the predominant isolates (60.7%), of which *E. coli* (44.6%) was the most predominant isolate followed by *Klebsiella* spp. (8.9%). Among Gram-positive bacteria, Coagulase-negative staphylococci*CoNS* were more frequently isolated (28.6%) followed by *S. aureus* (10.7%).

3.4. Factors Associated with Asymptomatic Bacteriuria {#sec3.4}
-----------------------------------------------------

In bivariate analysis, variables such as history of UTI, catheterization, the age group of 18--26 years old, the average monthly income of the participants \<1000 birr, habit of postcoital urination, direction of wiping after genital wash, and educational status were significant at *p* value \<0.25 and candidates for multivariable analysis.

In multivariable analysis, catheterization, direction of wiping after genital wash, postcoital urination remained statistically significant at *p* value less than 0.05. Study participants who have experienced catheterization had higher odds of significant bacteriuria than those who did not experience catheterization (AOR = 3.214; 95% CI: 1.643, 6.284). The study participants who wipe their genitals after genital wash from back to front were 2.9 times more likely to develop ASB than those who wipe from front to back direction (AOR = 2.913; 95% CI: 1.595, 5.320). The study participants who do not have the habit of postcoital urination had higher odds than those who have the habit of postcoital urination (AOR = 2.96; 95% CI: 1.207, 7.266) ([Table 3](#tab3){ref-type="table"}).

3.5. Gram-Positive Isolates {#sec3.5}
---------------------------

Most of the Gram-positive isolates were highly sensitive to Ceftriaxone (90.9%). *CoNS* showed higher sensitivity to Augmentin (75.0) and Ceftriaxone (87.5%), whereas they showed resistance to Clindamycin (68.7%) and Ampicillin (62.5%), while *S. aureus* showed sensitivity to Ceftriaxone (100%), Gentamycin (66.7%), and Augmentin (66.7%). Most of the Gram-positive isolates were highly resistant to Ampicillin (63.6%) and Clindamycin (71.4%).

3.6. Gram-Negative Isolates {#sec3.6}
---------------------------

Gram-negative bacteria isolates showed higher sensitivity to Ceftriaxone (88.2%), Gentamycin (67.5%), and Augmentin (64.7%), while showed resistance to Ampicillin (70.5%) and clindamycin (50.0%). From Gram-negative bacteria isolates, Pseudomonas spp. were 100% sensitivity to each of Gentamycin and Ceftriaxone, whereas they were 50% resistant to each of Ampicillin and Erythromycin. *E. coli* were sensitive to Ceftriaxone (92.0%), Gentamycin (68.0%), and Augmentin (60.0%), while they were resistant to Ampicillin (80.0%) ([Table 4](#tab4){ref-type="table"}).

4. Discussion {#sec4}
=============

In this study, the overall prevalence of ASB was 19.9%. Six different bacterial isolates were identified, of which *E.coli,* the most dominant isolate (44.6%), was followed by Coagulase-negative staphylococci (28.6) and *S. aureus* (10.7%). Direction of wiping after genital wash, catheterization, and postcoital urination increase the odds of asymptomatic bacteriuria.

This finding was consistent with previous studies from Adigrat, Ethiopia (21.2%) \[[@B5]\], and Ghana (17.5%) \[[@B14]\]. But it was relatively higher in other studies reported from Bahir Dar, Ethiopia (11.5%) \[[@B9]\], and countries such as India (13.2%) \[[@B15]\] and Nigeria (10.6%) \[[@B16]\]. On the contrary, this finding was relatively lower than the result reported from Saudi Arabia \[[@B17]\] and Egypt (29%) \[[@B18]\]. This difference in findings might be attributed to differences in sample size, geographical variation, and socioeconomic condition, awareness, and predisposing factors. There is a report, which indicates the prevalence of asymptomatic bacteriuria in pregnant women in the world which is known to vary from geographical region to region even within the same country \[[@B19]\].

Most of the isolated bacteria in this study were Gram negative (60.7%) which agrees with the study report from Adama, Ethiopia (72.6%) \[[@B10]\], and Kenya (55.3%) \[[@B19]\]. This finding is supported by the fact that Gram-negative bacteria have a unique structure which assists in attachment to the uroepithelium and prevents pathogens from being washed away by urine and the same characteristics allow for growth and tissue invasion resulting in invasive infection and pyelonephritis during pregnancy \[[@B1]\].

*Escherichia coli* was the most dominant isolate (44.6%) in this study. This finding was comparable with the study conducted in Ethiopia: Adigrat (34.6%) \[[@B5]\], Adama (37.3%) \[[@B10]\], and other parts of the world, such as India (57.7%) \[[@B1]\].

In this study, participants who wipe genitals after wash from back to front direction were more likely to develop ASB. This finding agrees with the finding reported from Cairo, Egypt \[[@B20]\] and Ismailia city of Egypt \[[@B18]\]. This is due to that bacteria from intestine might be transferred to female genital through wiping.

In the current study, participants who have experienced catheterization were three-fold more likely to develop ASB. This finding is similar to a study reported in Baghdad \[[@B4]\]. Catheter-associated ASB occurs when bacteria in a catheter bypass the body\'s defense mechanisms and enter the bladder \[[@B19]\]. However, the study conducted in Bahirdar, Ethiopia, \[[@B9]\] showed there was no significant association between catheterization and prevalence of ASB. The observed variation might be due to the variation in the catheterization technique/sterility and sample size difference.

In the current finding, study participants who have no habit of postcoital urination were two-fold more likely to develop ASB than their counterpart. Another study conducted in Cairo, Egypt, reported that the pregnant women who do not urinate after coitus were eight-fold more likely to develop ASB than those who have the habit of postcoital urination \[[@B21]\]. This might be because postcoital urination cleans the urethra from the bacteria entered during sexual intercourse.

In this study, Gram-positive isolates (*CoNS* and *S. aureus*) showed sensitivity to Ceftriaxone (90.5%), Augmentin (71.4%), and Gentamycin (52.4%) while they showed resistance to Ampicillin (63.6%) and Clindamycin (71.4%). On the contrary, the study conducted in Dessie Hospital, Ethiopia, showed that Gram-positive isolates showed sensitivity to Ceftriaxone (100%) and Clindamycin (62.2%) while they showed resistance to Tetracycline (62.2%) and Erythromycin (56.7%) \[[@B22]\].

Prescription of antibiotics without laboratory guidance as well as over-the-counter sales of antibiotics without prescription are a probable factor for increased bacterial resistance to antimicrobial agents \[[@B10], [@B22]\]. For instance, Ampicillin and other antimicrobials are freely available in local pharmacies, and people could purchase without prescription and use them with less adherence in Ethiopia. In general, the importance of screening and treatment of ASB include possible benefits such as reductions in incidence of maternal mortality, maternal sepsis, pyelonephritis, perinatal mortality (≥20 weeks of gestation), spontaneous abortion (\<20 weeks of gestation), neonatal sepsis, preterm delivery (\<37 weeks of gestation), and low birth weight (≤2500 g) \[[@B11], [@B12]\].

5. Conclusion {#sec5}
=============

The overall prevalence of ASB among pregnant women in the present study was higher than previous studies conducted in Ethiopia. The current study revealed that postcoital urination, catheterization, and direction of wiping after genital wash were the factors that aggravated the occurrence of ASB in pregnant women. The most frequently identified isolate was *E. coli* (44.6%). Most of the bacterial isolates in this study were sensitive to Ceftriaxone and Augmentin while they were resistant to Ampicillin and Clindamycin. Of the total isolated bacteria, 54% of Gram-positive and 61.8% of Gram-negative bacteria showed resistance to two or more antimicrobials. Based on the above mentioned finding, health education should be provided for pregnant women on the identified ASB predisposing factors. Ceftriaxone, Augmentin, and Gentamycin can be used for the treatment of ASB among pregnant women, while Ampicillin and Clindamycin might not be used for ASB treatment in the study area. Finally, microbiological examinations for the isolation and culture identification of the bacteria causing ASB should be performed and selection of the appropriate antibiotic should be based on the drug susceptibility pattern of isolated bacteria.
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###### 

Sociodemographic characteristics of pregnant women attending at Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia, 2019 (*n* = 281).

  Characteristics                  Frequency number (%)
  -------------------------------- ----------------------
  *Age group*                       
  18--26                           157 (55.9)
  27--34                           107 (38.1)
  35--44                           17 (6.0)
                                   
  *Marital status*                  
  Married                          258 (91.8)
  Divorced                         20 (7.1)
  Single                           1 (0.4)
  Widowed                          2 (0.7)
                                   
  *Residence*                       
  Urban                            126 (44.8)
  Rural                            155 (55.2)
                                   
  *Monthly income*                  
  \<1000                           90 (32)
  1000--1999                       50 (17.8)
  2000--2999                       72 (25.6)
  \>2999                           69 (24.6)
                                   
  *Religion*                        
  Orthodox                         56 (19.9)
  Protestant                       32 (11.4)
  Muslim                           190 (67.6)
  Others                           3 (1.1)
                                   
  *Educational status*              
  Do not read and write            78 (27.8)
  Primary (1--8 grade) school      112 (39.9)
  Secondary (9--12 grade) school   45 (16.0)
  College and above                46 (16.4)
                                   
  *Occupation*                      
  Student                          8 (2.8)
  House wife                       181 (64.4)
  Merchant                         41 (14.6)
  Civil servant                    49 (17.4)
  Others                           2 (0.7)

###### 

Pregnancy, Clinical condition, and behavior-related factors of pregnant women attending at Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia, 2019 (*n* = 281).

  Characteristics                    Frequency (%)
  ---------------------------------- ---------------
  *Gravida*                           
  Nulligravida                       69 (24.6)
  Primigravida                       96 (34.2)
  Multigravida                       58 (20.6)
  Grand multigravida                 58 (20.6)
                                     
  *Gestational period*                
  First trimester                    43 (15.3)
  Second trimester                   123 (43.8)
  Third trimester                    115 (41.0)
                                     
  *ANC follow-up*                     
  First visit                        65 (23.1)
  Second visit                       151 (53.7)
  Third visit                        35 (12.5)
  Fourth visit                       30 (10.7)
                                     
  *History of UTI*                    
  Yes                                105 (37.5)
  No                                 176 (62.7)
                                     
  *History of drug use*               
  Yes                                72 (25.6)
  No                                 209 (74.4)
                                     
  *Hypertension*                      
  Yes                                24 (8.5)
  No                                 257 (91.5)
                                     
  *Diabetes*                          
  Yes                                16 (5.7)
  No                                 265 (94.3)
                                     
  *Hemoglobin level*                  
  Anemic                             193 (68.7)
  Nonanemic                          88 (31.3)
                                     
  *History of catheterization*        
  Yes                                50 (17.8)
  No                                 231 (82.2)
                                     
  *Postcoital urination*              
  Yes                                65 (23.1)
  No                                 216 (76.9)
                                     
  *Postcoital washing*                
  Yes                                165 (58.4)
  No                                 116 (41.3)
                                     
  *Direction of wiping after wash*    
  Backward                           169 (60.1)
  Forward                            112 (39.9)
                                     
  *Sexual activities per week*        
  \<2 times                          228 (81.1)
  \>2 times                          53 (18.9)

###### 

Pregnancy-related and personal factors associated with ASB among pregnant women participated in the study at Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia, 2019 (*n* = 281).

  Characteristics                            Significant bacteriuria no. (%)   Nonsignificant bacteriuria no. (%)   Crude odds ratio (95% CI)   *p* value    Adjusted odds ratio (95% CI)
  ------------------------------------------ --------------------------------- ------------------------------------ --------------------------- ------------ ------------------------------
  *Gravida*                                                                                                                                                   
  Nulligravida                               14 (25.0)                         55 (24.2)                            1                                         
  Primigravida                               18 (32.1)                         78 (34.8)                            1.025 (0.432, 2.434)        0.805         
  Multigravida                               12 (21.4)                         46 (20.4)                            1.130 (0.500, 2.557)        0.956         
  Grand multigravida                         12 (21.4)                         46 (20.4)                            1.000 (0.407, 2.456)        0.956         
                                                                                                                                                             
  *Gestational period*                                                                                                                                        
  First trimester                            10 (17.9)                         36 (15.9)                            1                                         
  Second trimester                           23 (41.1)                         102 (44.9)                           1.186 (0.510, 2.754)        0.520         
  Third trimester                            23 (41.1)                         89 (39.2)                            1.99 (0.661, 1.506)         0.692         
                                                                                                                                                             
  *Hemoglobin level*                                                                                                                                          
  Anemic                                     40 (71.4)                         153 (68.0)                           1.185 (0.623, 2.255)        0.621         
  Nonanemic                                  16 (28.6)                         72 (32.0)                            1                                         
                                                                                                                                                             
  *Sexual activities/week*                                                                                                                                    
  0--2                                       43 (76.8)                         185 (82.2)                           1                                         
  ≥2                                         13 (23.2)                         40 (17.8)                            0.715 (0.352, 1.452)        0.354         
                                                                                                                                                             
  *Hypertension*                                                                                                                                              
  Yes                                        7(12.5)                           17 (7.5)                             0.929 (0.296, 2.915)        0.899         
  No                                         49 (87.5)                         208 (92.4)                           1                                         
                                                                                                                                                             
  *Diabetes*                                                                                                                                                  
  Yes                                        6 (10.7)                          10 (6.3)                             1.187 (0.387, 3.640)        0.764         
  No                                         50 (89.3)                         215 (93.7)                           1                                         
                                                                                                                                                             
  *ANC follow-up*                                                                                                                                             
  1st visit                                  16 (28.6)                         49 (21.8)                            1                                         
  4th visit                                  6 (10.7)                          24 (10.7)                            0.766 (0.266, 2.205)        0.744         
                                                                                                                                                             
  *Postcoital washing*                                                                                                                                        
  No                                         90 (51.8)                         29 (39.6)                            0.642 (0.357, 1.157)        0.24         1.277 (0.666, 2.447)
  Yes                                        27 (48.2)                         137 (60.4)                           1                           1             
                                                                                                                                                             
  *History of antimicrobial use*                                                                                                                              
  Yes                                        15 (26.8)                         57 (25.1)                            0.927 (0.478, 1.800)        0.824         
  No                                         41 (73.2)                         168 (74.9)                           1                                         
                                                                                                                                                             
  *Catheterization*                                                                                                                                           
  Yes                                        19 (38)                           31 (62)                              3.214 (1.643, 6.284)        0.001^*∗*^   3.122 (1.378, 7.072)
  No                                         37 (16.1)                         194 (83.9)                           1                           1             
                                                                                                                                                             
  *History of UTI*                                                                                                                                            
  Yes                                        29 (51.8)                         76 (33.8)                            1                                         
  No                                         27 (37.5)                         149 (66.2)                           0.478 \[0.26, 0.864\]       0.181^*∗*^   1.424 (0.719, 2.820)
                                                                                                                                                             
  *Postcoital urination*                                                                                                                                      
  Yes                                        6 (10.7)                          59 (26.0)                            1                                         
  No                                         50 (89.3)                         168 (74.0)                           2.962 (1.207, 7.266)        0.018^*∗*^   3.160 (1.173, 6.514)^*∗∗*^
                                                                                                                                                             
  *Direction of wiping after genital wash*                                                                                                                    
  Forward                                    34 (60.7)                         79 (34.8)                            2.913 (1.595, 5.320)        0.001^*∗*^   2.853 (1.255, 4.320)^*∗∗*^
  Backward                                   22(39.3)                          148 (65.2)                           1                                         

CI, confidence interval; ^*∗*^*p* \< 0.25; ^*∗∗*^*p* value \<0.05; OR: odds ratio.

###### 

Antimicrobial susceptibility pattern of Gram-negative bacteria isolated from urine culture of pregnant women with asymptomatic bacteriuria at Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia, 2019.

  Isolates             Number      Pattern     AMP         AUG         A           CN          COT         CD          T           CRO       E
  -------------------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- --------- ---------
  *E. coli*            25                      *N* (%)     *N* (%)     *N* (%)     *N* (%)     *N* (%)     *N* (%)     *N* (%)     *N* (%)   *N* (%)
  S                    ---         15 (60.0)   13 (52.0)   17 (68.0)   14 (56.0)   9 (36.0)    10 (40.0)   23 (92.0)   13 (52.0)             
  I                    5 (20.0)    4 (16.0)    3 (12.0)    4 (16.0)    3 (12.0)    4 (16.0)    5 (20.0)    1 (4.0)     4 (16.0)              
  R                    20 (80.0)   6 (24.0)    9 (36.0)    4 (16.0)    8 (32.0)    12 (48.0)   10 (40.0)   1 (4.0)     7 (28.0)              
                                                                                                                                             
  *Klebsiella* spp.    5                                                                                                                      
  S                    1 (20)      4 (80)      2 (40)      3 (60)      3 (60)      2 (40)      2 (40)      3 (60)      ---                   
  I                    3 (60)      ---         ---         2 (40)      2 (40)      ---         1 (20)      2 (40)      1 (20)                
  R                    1 (20)      1 (20)      3 (60)      ---         ---         3 (60)      2 (40)      ---         4 (80)                
                                                                                                                                             
  *Pseudomonas* spp.   2           S           1 (50)      1 (50)      1 (50)      2 (100)     ---         1 (50)      1 (50)      2 (100)   ---
  I                    ---         ---         ---         ---         2 (100)     1 (50)      ---         ---         1 (50)                
  R                    1 (50)      1 (50)      1 (50)      ---         ---         ---         1 (50)      ---         1 (50)                
                                                                                                                                             
  *Proteus* spp.       2                                                                                                                      
  S                    ---         2 (100)     2 (100)     1 (50)      ---         ---         ---         2 (100)     1 (50)                
  I                    ---         ---         ---         ---         ---         ---         ---         ---         ---                   
  R                    2 (100)                             1 (50)      2 (100)     2 (100)     2 (100)     ---         1 (50)                
                                                                                                                                             
  Total                34                                                                                                                     
  S                    2 (5.8)     22 (64.7)   18 (52.9)   23 (67.5)   17 (50.0)   12 (35.3)   13 (38.2)   30 (88.2)   15 (44.0)             
  I                    8 (23.5)    4 (11.8)    3 (8.8)     6 (17.8)    7 (20.5)    5 (14.7)    6 (17.8)    3 (8.8)     6 (17.8)              
  R                    24 (70.5)   8 (23.5)    13 (38.2)   5 (14.7)    10 (29.4)   17 (50.0)   15 (44.0)   1 (3.0)     13 (38.2)             

AMP, Ampicillin; CRO, Ceftriaxone; A, Amoxicillin; CN, Gentamicin; COT, Cotrimoxazole; AUG, Augmentin; ERY, Erythromycin; CD, Clindamycin; T, Tetracycline; *CoNS*, coagulase-negative staphylococci species; S, sensitive; I, intermediate; R, resistant.

[^1]: Academic Editor: Todd R. Callaway
